CS Paper Radar

Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools

Bryce Cai, Geetha Jeyapragasan, Samira Nedungadi, Jake Yukich, Seth Donoughe

cs.AI cs.CYq-bio.QM ·submitted 2026-09-05 02:28 UTC · v1
publishedbenchmarkhighly cited

Abstract

We introduce ABLE, a benchmark for evaluating LLM agents' ability to use biological AI models (BAIMs), such as ProteinMPNN and AlphaFold3, in dual-use protein design workflows. ABLE assesses agent performance through a set of tasks spanning structure retrieval, sequence generation, and design validation. We evaluate 15 frontier models and find that seven refuse all tasks, while the remaining models exhibit substantial performance differences. Claude Sonnet 4 and Gemini 3 Pro achieve the highest scores across information retrieval, tool selection, and tool use. We further compare model performance on a subset of tasks against an expert human baseline. Our results suggest that current LLMs can substantially lower barriers to protein design, but remain inconsistent in planning, strategy generation, and integrating biological knowledge with tool use.

Comment
Last revised in February 2026; presented without further revision. An earlier revision at was presented at the NeurIPS 2025 Workshop on Biosecurity Safeguards for Generative AI; see https://openreview.net/forum?id=fDysOrWaGd

Closest papers

Nearest neighbours by meaning across the whole index.

AgentFold: Closed-Loop Agentic Search for Protein Folding Model Design

cs.AI ·2026-08-27 ·Mingquan Liu, Jiangyu Chen, Hanqun Cao, Xujun Zhang, Pengsen Ma +7 more
top venuecode/data similarity 0.74
Abstract

Scientific LLM agents have shown promise in literature reasoning, tool use, and experiment planning, but it remains unclear whether they can autonomously improve large, tightly coupled scientific machine-learning systems through executable code changes and computationally expensive validation. We study this question in protein folding, where progress requires coordinated architectural modifications, multi-objective evaluation, and domain-aware interpretation. We present AgentFold, a multi-agent framework that formulates folding-model development as a closed-loop search over executable code variants. Starting from ESMFold, AgentFold proposes hypotheses, implements and debugs code-level modifications, evaluates model variants, analyzes experimental outcomes, and stores both successful and failed interventions in structured memory. An MCTS-style policy allocates computational resources across high-scoring search branches. On an engineering-scale protein-folding codebase comprising more than 2,000 lines of code, AgentFold explores approximately 80 model variants using approximately 5,000 GPU-hours and 170 million LLM tokens. Under a matched computational budget, AgentFold improves the best lDDT by 7.5% over independent Codex proposals and outperforms a random-search control. Beyond model improvement, the resulting intervention traces reveal recurring empirical design patterns: stable gains tend to arise from early, soft, learnable priors and gated refinement, whereas direct geometric perturbations and geometry-conditioned feedback often destabilize training. The code and experimental resources are publicly available at https://github.com/lmqfly/AgentFold.

0.51

ReproBAIT: Can coding agents build their own biological AI tools?

cs.AI cs.CYcs.LG ·2026-10-14 ·Shiv Muthupandiyan, Tolga H. Dur, Mac Walker, Timo Flesch, Mahmoud Ghanem +6 more
code/data similarity 0.72
Abstract

Large language models are increasingly competent at leveraging scientific knowledge and existing computational tools to execute complex workflows. At present, little information exists on their ability to reconstruct tools when given limited descriptions of such tools. We introduce an evaluation titled ReproBAIT (Reproducing Biological AI Tools), which measures the ability of coding agents to design, implement, and train biological AI tools taken from published research across a range of information access conditions. The coding agent is securely sandboxed without internet access and receives training data, a fixed time and compute budget, and limited information about the tool to replicate. We then score the reproduced biological AI tool based on its performance (tool-specific metrics) on held-out data. We evaluated a set of biological AI tools of varying complexities: ProteinMPNN, an inverse protein folding tool, RFdiffusion3, an all-atom generative diffusion tool, and a closed-source molecular design tool. We institute a methodology to check for memorisation, as the open source tools are likely to be included in models' pretraining corpus. Across a range of leading closed- and open-source coding agents, we find substantial reproduction capability for some selected tools, though limited capability for a highly complex tool. We find moderate evidence consistent with memorisation, varying across coding agents. These results suggest that tool developers need to be increasingly cautious when releasing information about the tools publicly; re-creation of the tool based on such information could undermine a tool's commercial value or invalidate dual-use managed access strategies.

0.47

Can agents reliably design therapeutic antibodies?

cs.LG q-bio.QM ·2026-10-31 ·Asli Alpman, Nick Bhattacharya, Aaron Solomon, Hunter Elliott
similarity 0.71
Abstract

Recent work has demonstrated agents driving protein design workflows, either through orchestration of specialized tools or direct manipulation of sequences. Yet the fidelity with which agents follow protein design instructions and the factors contributing to their effectiveness remain understudied. We examine agentic antibody design under two settings: when explicit molecular-editing instructions are provided and when agents receive only previously-scored sequences and are prompted to propose improvements. We call the first task-guided and the second black-box design. For the task-guided setting, we curate ten expert-validated affinity-improvement tasks and show that LLM judges closely reproduce programmatic evaluations of instruction following. We then study two augmentations: access to antibody-relevant tools and to previously scored design history. Tools improve instruction following (IF) and sequence space exploration while reducing optimization performance, whereas design history reduces IF but improves optimization performance at the expense of exploration. Finally, we combine taskguided and black-box design within an in silico optimization loop and show that our agentic optimizer performs comparably to an established Bayesian optimization baseline.

0.08

MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

cs.AI ·2026-10-29 ·Yikun Zhang, Xiwei Cheng, Mingze Yuan, Yu Zhang, Brian Shim +13 more
community pick similarity 0.70
Abstract · v2: updated the author list

Molecular discovery requires navigating vast combinatorial search spaces while balancing competing biological objectives. AI agents can automate expert-defined molecular design protocols, but automation alone does not address how to optimize workflows for new tasks or improve their development through experience. Here we introduce MoLRSI, an AI agent that combines systematic optimization of workflows and model architectures with persistent cross-task memory to recursively improve its search policy for molecular discovery. Workflow performance, refinement outcomes, and execution feedback guide subsequent searches, allowing the agent to improve both its workflows and its strategy for developing them. We evaluate MoLRSI in two challenging molecular discovery settings that require balancing competing properties. In antibiotic discovery, MoLRSI developed a screening workflow balancing antibacterial activity, cytotoxicity and structural novelty, achieving an experimental hit rate of 15.9%, compared with 8.7% for a previous expert-led workflow using the same training data and screening library. In de novo peptide-MHC binder design, MoLRSI developed workflows that jointly consider target binding and specificity, producing eight experimentally validated hits against MART-1 and SARS-CoV-1 pMHCs with preferential binding over tested off-targets while Claude Science completely failed. These findings demonstrate how experience-guided workflow optimization can address competing discovery objectives while improving the search strategies used in subsequent campaigns.

0.39

PROTEAN: Beyond De Novo Generation - Can LLM Agents Perform Text-Guided Protein Structure Editing?

cs.CE ·2026-10-13 ·Encheng Su, Xinping Liu, Yizhou Wang, Bozitao Zhong, Pengze Li +9 more
benchmark similarity 0.70
Abstract

Generative AI has achieved remarkable success in de novo protein design, yet protein engineering typically begins with existing, characterized proteins. The primary demand is targeted local editing, e.g., engineering a specific region to optimize affinity, alter immunogenicity, or improve stability, while strictly preserving core catalytic motifs and overall scaffold integrity. However, no standardized framework currently exists for carrying out and evaluating such edits. In current generative-design workflows, researchers often need to manually specify complex low-level parameters and rely on repetitive, trial-and-error sampling and evaluation across generative backends to search for viable conformations. While large language models (LLMs) offer an intuitive interface to express these goals using natural language, prevailing structure-generation models cannot directly interpret high-level human instructions. To bridge this gap, we introduce PROTEAN, a standardized benchmark for text-guided protein structural editing. PROTEAN comprises 380 sub-tasks spanning six intervention families and evaluates a two-stage pipeline in which an LLM translates natural-language goals into backend-specific geometric constraints and a generative model remodels the protein backbone. A two-tier evaluation separates geometric compliance, including target attainment and off-target scope fidelity, from biophysical realizability assessed by inverse folding and refolding consistency. Across five frontier LLMs paired with three backends, strict end-to-end biophysical success starts at just 7.0%. Ablation studies show that LLM constraint compilation is already highly accurate, whereas the main bottlenecks are backend-specific scope leakage and refolding failure. PROTEAN provides an open testbed for developing autonomous, multi-backend macromolecular design agents.

0.18

Federation Is Nearly Free, Reasoning Is Not: Tradeoffs for AI Co-Scientists in Protein Characterization Workflows

cs.AI cs.MAq-bio.QM ·2026-08-25 ·Maia Kapur, Timothy Boe, Abby Jerger, Paul Rigor
similarity 0.68
Abstract · 24 Pages, 4 main figures, 5 main tables, 2 supplementary figures

Natural language driven autonomous co-scientist workflows involve a fundamental trade-off between flexibility and reasoning at the expense of determinism, reproducibility, and observability. Such agents increasingly must communicate across institutional boundaries, where federation topology can shape latency and cost. We systematically evaluated these tradeoffs using a controlled ablation on a production agentic platform for science. We use a verifiable task: given a protein sequence, we ask an agent to confidently characterize its function by routing across common tools. We compare federation topology, classic RL vs LLM-driven harnesses, language model, and prompt expertise. We also stratify results by protein novelty. We find that the choice of LLM dominated prediction quality far more than topology or prompting (Opus ~92%-94% vs o4-mini ~40%-50%). The PPO policy was nearly as accurate as the best LLM (88%) at zero token cost, fastest latency, and perfect consistency, but yields no reasoning trace. Expert prompted LLMs reached the highest accuracy but were high-cost and less consistent; prompt dependence was largest when the task was hardest. Federation imposed a negligible penalty on performance. These results offer actionable guidance for deploying agents for scientific workflows: for routine, verifiable tasks, a cheap deterministic policy delivers near-frontier accuracy with complete reproducibility, while flexible LLM reasoning is best reserved for open-ended discovery.

0.33

AI for Biologists: The Knowledge Boundaries of Foundation Models in the Age of Agentic Systems

cs.AI q-bio.BM ·2026-11-12 ·Tian Cai, Andrew Kleist, Jaimin Patel, Duccio Malinverni, Alexander K. Taylor +3 more
similarity 0.68
Abstract · To be published on Annual Review Biomedical Data Science

Artificial intelligence (AI) is changing how biological research is done. Biological foundation models trained on millions of nucleotides, protein, and single-cell measurements predict protein structures, mutation effects, and cellular responses to genetic perturbations. Agentic systems, AI assistants built on large language models, can run multistep analyses from plain-language requests and increasingly call foundation models as tools. Yet it is often unclear when these models' outputs can be trusted. We frame this as a model's knowledge boundary: the range of inputs, tasks, and conditions over which its outputs are reliable. This review explains how foundation models are built and proposes that five design elements (data, architecture, training scheme, evaluation scheme, and post-analysis) define this boundary. We examine evidence on where current models succeed or fail and present standardized descriptions of model limits so that researchers, and the agents acting for them, can use these tools reliably.

0.10

Aptamers as a sandbox for lab-in-the-loop agentic molecular discovery

cs.AI q-bio.BMq-bio.QM ·2026-10-17 ·Zachary Cutts, John Coller, Rachel Chen, Hua Tang, Mathias Bellaiche +7 more
hot direction similarity 0.68
Abstract · Equal leadership (co-senior authors): Pooja Rao and Annalisa Pawlosky. 34 pages, 4 main figures, 1 main table, 3 supplementary figures, 4 su…

Despite breakthroughs in AI-driven molecular generation, existing discovery pipelines operate largely in silico, with wet-lab feedback reserved for validation rather than iterative improvement. Whether large language model (LLM)-based reasoning agents can accelerate de novo discovery by iterating with lab data remains unproven. Here we use protein-binding aptamer design as a sandbox (1-2 week cycles, \$1-\$3 per candidate) to demonstrate a wet lab in a closed loop with AI systems. We tasked agentic pipelines with developing aptamer binders against $α$-thrombin and myoglobin across three design-test-improve cycles ($\sim$1,000 candidates per round; $\sim$4,400 constructs). Statistically significant, bead-corrected on-target hit rates among new candidates rose across rounds from 0.0% in Round 1 to 26.0% in Round 2 and 42.1% in Round 3 on $α$-thrombin (37.1% excluding literature motif descendants), and from 10.2% in Round 1 to 3.7% in Round 2 and 33.5% in Round 3 on myoglobin. Single-clone bead-binding titrations of eight full-length $α$-thrombin candidates confirmed concordance with pooled sequencing enrichment (Pearson $r = 0.90$). In these assays, literature-derived motifs engineered by the agents to reduce off-target reactivity in the pooled screen reached apparent affinities of $K_D = 24.6$--$133$ nM, whereas de novo scaffolds showed low-micromolar binding ($K_D > 1\ μ$M). We also report how our pipelines used myoglobin binding data to exploit the G-quadruplex binder space, diagnose cross-reactivity as on-target specificity dropped from 75.0% to 19.1%, and recover by developing strategies that restored specificity to 72.4%. We demonstrate that empirical lab data is more valuable than existing computational proxies, showing how iterative experimental feedback enables AI agents to diagnose assay artifacts and refine molecular designs across rounds.

0.52